Form 4: Haemonetics Corp Executive Acquires Shares and Stock Options

Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, reports acquisition of common stock and stock options.

Summary

• On May 16, 2025, Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, acquired 3,200 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs vest in three equal annual installments starting on the first anniversary of the grant date.
• Each RSU represents a contingent right to receive one share of Haemonetics Corp's common stock when vested.
• Following the transaction, Miller beneficially owns 20,474 shares of common stock, including unvested RSUs previously reported.
• Miller also acquired 6,928 non-qualified stock options with an exercise price of $70.31, vesting in annual increments of 25% beginning on the first anniversary of the grant date, and expiring on 05/16/2032.
• After the transaction, Miller owns 6,928 derivative securities.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard insider transaction filing. The acquisition of shares and options could be interpreted as a positive signal, but it's a routine occurrence.

Positives

• The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company executive.

Key Dates

Keywords

Form 4, insider trading, stock options, restricted stock units, HAEMONETICS CORP, HAE, Laurie A. Miller, beneficial ownership